- KR₩99bn
- KR₩46bn
- KR₩19bn
Annual balance sheet for Bio-FD&C Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5,485 | 40,329 | 40,882 | 45,884 | 52,754 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,027 | 2,266 | 2,987 | 2,867 | 3,376 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9,173 | 44,894 | 45,726 | 50,847 | 58,154 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 13,091 | 12,217 | 13,263 | 13,644 | 13,342 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 23,040 | 59,036 | 62,813 | 67,316 | 73,450 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,751 | 5,981 | 4,091 | 3,980 | 3,408 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7,157 | 6,058 | 4,196 | 4,184 | 3,652 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 15,883 | 52,977 | 58,617 | 63,131 | 69,798 |
| Total Liabilities & Shareholders' Equity | 23,040 | 59,036 | 62,813 | 67,316 | 73,450 |
| Total Common Shares Outstanding |